Claudia Cazaux
About Claudia Cazaux
Claudia Cazaux is a Pharmacovigilance Manager at Pint Pharma, where she has worked since 2019. She has extensive experience in clinical research and medical operations across various companies in Latin America.
Current Role as Pharmacovigilance Manager
Claudia Cazaux serves as the Pharmacovigilance Manager at Pint Pharma since 2019. In this role, she oversees the safety monitoring of pharmaceutical products, ensuring compliance with regulatory requirements. Her responsibilities include analyzing adverse event reports and implementing risk management strategies to enhance patient safety. Claudia's expertise in pharmacovigilance contributes to the company's commitment to maintaining high safety standards in its product offerings.
Previous Experience at Pint Pharma
Claudia Cazaux previously worked at Pint Pharma in 2018 as a Medical Science Liaison (MSL) for eight months and as a Clinical Scientist Coordinator/MSL for three months. During her tenure, she engaged with healthcare professionals to provide scientific information and support clinical research initiatives. Her dual role allowed her to bridge the gap between clinical development and medical affairs.
Career at Abbott Laboratories and AbbVie
Claudia Cazaux has significant experience in the pharmaceutical industry, having worked at Abbott Laboratories from 2001 to 2012 in various roles, including Clinical Research Manager and Senior Area Medical Operations Manager for Latin America. She also served as Senior Manager of Affiliate Research at AbbVie from 2013 to 2016. Her positions involved overseeing clinical trials and managing medical operations across Latin America, enhancing her expertise in clinical research and operations.
Educational Background
Claudia Cazaux earned her PhD from the University of Buenos Aires, where she studied from 1992 to 1996. She also holds a degree in Biochemistry, which she obtained from the same university between 1984 and 1990. Her academic background laid the foundation for her extensive career in the pharmaceutical and clinical research sectors.
Research Experience and Teaching
Claudia Cazaux conducted four years of basic research in neuroimmunomodulation of ß2 receptor in hyperproliferative T lymphocytes at the National Council of Scientific and Technical Research, University of Buenos Aires. Additionally, she has eight years of teaching experience in the Physics and Mathematics Department at the University of Buenos Aires, where she contributed to the education of future scientists.